secwatch.observer — SEC 8-K summary
======================================

Issuer:     agilon health, inc. (AGL)
CIK:        0001831097
Form:       8-K
Filed at:   2022-03-03T23:59:59+00:00
Accession:  0000950170-22-002817
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

agilon health Q4 revenue up 44% to $463M; FY2021 net loss $407M; guides to positive Adj EBITDA in 2022
--------------------------------------------------------------------------------

- Q4 revenue $463M (+44% YoY); FY2021 revenue $1.83B (+50%).
- Net loss widened to $57M in Q4 (vs $24M); FY2021 net loss $407M (incl $292M stock comp).
- Adjusted EBITDA loss $27M in Q4; FY2021 loss $39M vs $6M gain in 2020.
- Total members live on platform up 82% to 238,000; Medicare Advantage members up 42% to 186,300.
- FY2022 guidance: revenue $2.505B-$2.590B; Adj EBITDA $0-$10M; adds 80,000 MA members from 7 new partners in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831097/000095017022002817/0000950170-22-002817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831097/000095017022002817/agl-20220303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-002817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer